X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA JUBILANT LIFE SCIENCES ELDER PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -0.2 27.4 - View Chart
P/BV x 0.1 5.6 1.8% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ELDER PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
JUBILANT LIFE SCIENCES
Mar-14
ELDER PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs380187 203.4%   
Low Rs18865 288.8%   
Sales per share (Unadj.) Rs491.2364.3 134.8%  
Earnings per share (Unadj.) Rs-3.26.8 -46.5%  
Cash flow per share (Unadj.) Rs14.424.5 58.8%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %02.4 0.0%  
Book value per share (Unadj.) Rs376.5164.9 228.3%  
Shares outstanding (eoy) m20.54159.28 12.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.60.3 167.3%   
Avg P/E ratio x-89.318.4 -485.2%  
P/CF ratio (eoy) x19.75.1 383.4%  
Price / Book Value ratio x0.80.8 98.8%  
Dividend payout %043.8 0.0%   
Avg Mkt Cap Rs m5,83320,061 29.1%   
No. of employees `000NA6.2 0.0%   
Total wages/salary Rs m2,17911,052 19.7%   
Avg. sales/employee Rs ThNM9,383.0-  
Avg. wages/employee Rs ThNM1,786.9-  
Avg. net profit/employee Rs ThNM176.3-  
INCOME DATA
Net Sales Rs m10,08958,034 17.4%  
Other income Rs m257191 134.6%   
Total revenues Rs m10,34658,224 17.8%   
Gross profit Rs m-7925,786 -13.7%  
Depreciation Rs m3612,812 12.8%   
Interest Rs m2,7563,237 85.1%   
Profit before tax Rs m-3,653-72 5,066.4%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7132,145 173.1%   
Tax Rs m125696 18.0%   
Profit after tax Rs m-651,090 -6.0%  
Gross profit margin %-7.810.0 -78.7%  
Effective tax rate %-3.4-965.9 0.4%   
Net profit margin %-0.61.9 -34.5%  
BALANCE SHEET DATA
Current assets Rs m9,24029,280 31.6%   
Current liabilities Rs m9,99838,912 25.7%   
Net working cap to sales %-7.5-16.6 45.3%  
Current ratio x0.90.8 122.8%  
Inventory Days Days4684 54.9%  
Debtors Days Days6051 118.3%  
Net fixed assets Rs m10,12455,712 18.2%   
Share capital Rs m206155 133.1%   
"Free" reserves Rs m5,58220,968 26.6%   
Net worth Rs m7,73426,265 29.4%   
Long term debt Rs m4,88917,169 28.5%   
Total assets Rs m22,88288,606 25.8%  
Interest coverage x-0.31.0 -33.3%   
Debt to equity ratio x0.60.7 96.7%  
Sales to assets ratio x0.40.7 67.3%   
Return on assets %11.84.9 240.8%  
Return on equity %-0.84.2 -20.4%  
Return on capital %22.311.6 192.9%  
Exports to sales %3.037.8 8.0%   
Imports to sales %0.416.5 2.6%   
Exports (fob) Rs m30721,933 1.4%   
Imports (cif) Rs m439,567 0.5%   
Fx inflow Rs m30722,004 1.4%   
Fx outflow Rs m12511,749 1.1%   
Net fx Rs m18110,255 1.8%   
CASH FLOW
From Operations Rs m11,7548,026 146.4%  
From Investments Rs m-561-1,744 32.1%  
From Financial Activity Rs m-6,762-4,447 152.0%  
Net Cashflow Rs m4,4321,834 241.6%  

Share Holding

Indian Promoters % 39.6 45.6 86.8%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 7.5 8.7 86.2%  
FIIs % 16.8 21.2 79.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 21.1 171.1%  
Shareholders   16,479 23,815 69.2%  
Pledged promoter(s) holding % 77.6 15.9 489.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SUN PHARMA  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - LUPIN LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS